Showing results (1-10 of 609) with videos related to
Sort By:
Pageof 61
Antimicrobial Agents and Chemotherapy|May 20, 2020
Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are ImperativeChristian M Gill, Tomefa E Asempa, David P NicolauThe Journal of Antimicrobial Chemotherapy|October 26, 2020
Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection modelChristian M Gill, Tomefa E Asempa, David P NicolauAntibiotics (Basel, Switzerland)|October 30, 2020
Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosaChristian M Gill, Tomefa E Asempa, David P NicolauMicrobiology Spectrum|April 4, 2022
Comparison of Zinc Concentrations in the Broth of Commercial Automated Susceptibility Testing Devices (Vitek 2, MicroScan, BD Phoenix, and Sensititre)Tomefa E Asempa, Christian M Gill, Vindana Chibabhai, et al.The Journal of Antimicrobial Chemotherapy|March 24, 2022
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48Tomefa E Asempa, Abigail K Kois, Christian M Gill, et al.Journal of Clinical Microbiology|April 3, 2020
Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosaChristian M Gill, Maxwell J Lasko, Tomefa E Asempa, et al.The Journal of Antimicrobial Chemotherapy|January 10, 2023
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48Tomefa E Asempa, Abigail K Kois, Christian M Gill, et al.BMC Microbiology|July 22, 2020
EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrationsMaxwell J Lasko, Christian M Gill, Tomefa E Asempa, et al.Clinical Interventions in Aging|November 11, 2017
Clostridium difficile infection in the elderly: an update on managementTomefa E Asempa, David P NicolauThe Journal of Antimicrobial Chemotherapy|July 31, 2023
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and cliniciansAliaa Fouad, Christian M Gill, Patricia J Simner, et al.Pageof 61